FERRARA, ROBERTO
FERRARA, ROBERTO
Facoltà di Medicina e Chirurgia
A Case of William's Syndrome in a Ugandan Child: A Feasible Diagnosis Even in a Low-Resource Setting
2021-01-01 Mapelli, Massimo; Zagni, Paola; Calbi, Valeria; Twalib, Aliku; Ferrara, R; Agostoni, Piergiuseppe
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report
2015-01-01 C, Ciccarese; Ferrara, R; E, Fantinel; C, Zecchetto; F, Simionato; E, Grego; S, Ortolani; M, Caccese; D, Bimbatti; S, Cingarlini; M, Brunelli; A, Andreini; G, Tortora; F, Massari
Adenosine Pathway in NSCLC With Molecular Drivers: Can Oncogene Addiction Translate Into Immune Addiction?
2022-01-01 Ferrara, R; Milani, Matteo; Garassino Marina, Chiara; Colombo Mario, Paolo; Sangaletti, Sabina
Adjuvant epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for the treatment of people with resected stage I to III non‐small‐cell lung cancer and EGFR mutation
2022-01-01 Occhipinti, Mario; Ferrara, R; Imbimbo, Martina; Simeon, Vittorio; Fiscon, Giulia; Marchal, Corynne; Skoetz, Nicole; Viscardi, Giuseppe
Adjuvant therapy for resected early-stage small-cell lung cancer: is now time to rethink about that?
2016-01-01 Ferrara, Roberto; Caccese, Mario; Cuppone, Federica; Bria, Emilio; Tortora, Giampaolo; Pilotto, Sara
Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: a retrospective international multicentre study
2018-01-01 Lai W., Victoria; Lebas, Louisiane; Barnes Tristan, A.; Milia, Julie; Ni, Ai; Gautschi, Oliver; Peters, Solange; Ferrara, R; Plodkowski Andrew, J.; Kavanagh, John; Sabari Joshua, K.; Clarke Stephen, J.; Pavlakis, Nick; Drilon, Alexander; Rudin Charles, M.; Arcila Maria, E.; Leighl Natasha, B.; Shepherd Frances, A.; Kris Mark, G.; Mazières, Julien; Li Bob, T.
ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations
2016-01-01 Peretti, U.; Ferrara, R; Pilotto, S.; Kinspergher, S.; Caccese, M.; Santo, A.; Brunelli, M.; Caliò, A.; Carbognin, L.; Sperduti, I.; Garassino, M.; Chilosi, M.; Scarpa, A.; Tortora, G.; Bria, E.
An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer
2015-01-01 Pilotto, Sara; Novello, Silvia; Peretti, Umberto; Kinspergher, Stefania; Ciuffreda, Ludovica; Milella, Michele; Carbognin, Luisa; Vavalà, Tiziana; Ferrara, Roberto; Caccese, Mario; Tortora, Giampaolo; Bria, Emilio
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers-Letter
2018-01-01 Ferrara, R; Susini, Sandrine; Marabelle, Aurelien
Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer
2018-01-01 Mezquita, Laura; Auclin, Edouard; Ferrara, R; Charrier, Melinda; Remon, Jordi; Planchard, David; Ponce, Santiago; Ares Luis, Paz; Leroy, Laura; Audigier-Valette, Clarisse; Felip, Enriqueta; Zerón-Medina, Jorge; Garrido, Pilar; Brosseau, Solenn; Zalcman, Gérard; Mazieres, Julien; Caramela, Caroline; Lahmar, Jihene; Adam, Julien; Chaput, Nathalie; Soria Jean, Charles; Besse, Benjamin
Association of the prognostic model iSEND with PD-1/L1 monotherapy outcome in non-small-cell lung cancer
2020-01-01 Park, Wungki; Mezquita, Laura; Okabe, Naoyuki; Chae Young, Kwang; Kwon, Deukwoo; Saravia, Diana; Auclin, Edouard; Planchard, David; Caramella, Caroline; Ferrara, R; Agte, Sarita; Oh, Michael; Mudad, Raja; Jahanzeb, Mohammad; Suzuki, Hiroyuki; Besse, Benjamin; Lopes, Gilberto
Atypical patterns of response and progression in the era of immunotherapy combinations
2020-01-01 Ferrara, R; Matos, Ignacio
Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors
2022-01-01 Campochiaro, C.; Farina, N.; Tomelleri, A.; Ferrara, R.; Viola, S.; Lazzari, C.; De Luca, G.; Raggi, D.; Bulotta, A.; Matucci-Cerinic, M.; Necchi, A.; Garassino, M.; Gregorc, V.; Dagna, L.
Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis
2021-01-01 Passiglia, Francesco; Cinquini, Michela; Bertolaccini, Luca; Del Re, Marzia; Facchinetti, Francesco; Ferrara, R; Franchina, Tindara; Larici Anna, R.; Malapelle, Umberto; Menis, Jessica; Passaro, Antonio; Pilotto, Sara; Ramella, Sara; Rossi, Giulio; Trisolini, Rocco; Novello, Silvia
Beyond First-Line Immunotherapy: Potential Therapeutic Strategies Based on Different Pattern Progressions: Oligo and Systemic Progression
2021-01-01 Prelaj, Arsela; Pircher Chiara, Carlotta; Massa, Giacomo; Martelli, Valentino; Corrao, Giulia; Lo Russo, Giuseppe; Proto, Claudia; Ferrara, R; Galli, Giulia; De Toma, Alessandro; Genova, Carlo; Jereczek-Fossa Barbara, Alicja; Braud Filippo, De; Garassino Marina, Chiara; Rebuzzi Sara, Elena
Brief Report: Canadian Cancer Trials Group IND.227: A Phase 2 Randomized Study of Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma (NCT02784171)
2023-01-01 Piccirillo, M. C.; Chu, Q.; Bradbury, P.; Tu, W.; Coschi, C. H.; Grosso, F.; Florescu, M.; Mencoboni, M.; Goffin, J. R.; Pagano, M.; Ciardiello, F.; Cecere, F. L.; Vincent, M.; Ferrara, R.; Dawe, D. E.; Hao, D.; Lee, C. W.; Morabito, A.; Gridelli, C.; Cavanna, L.; Iqbal, M.; Blais, N.; Leighl, N. B.; Wheatley-Price, P.; Tsao, M. -S.; Ugo, F.; El-Osta, H.; Gargiulo, P.; Gaudreau, P. -O.; Tu, D.; Sederias, J.; Brown-Walker, P.; Perrone, F.; Seymour, L.; Laurie, S. A.
Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists' perspective
2020-01-01 Lambertini, Matteo; Toss, Angela; Passaro, Antonio; Criscitiello, Carmen; Cremolini, Chiara; Cardone, Claudia; Loupakis, Fotios; Viscardi, Giuseppe; Meattini, Icro; Dieci Maria, Vittoria; Ferrara, R; Giusti, Raffaele; Maio Massimo, Di
CD8+PD-1+ to CD4+PD-1+ ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockers
2022-01-01 Duchemann, Boris; Naigeon, Marie; Auclin, Edouard; Ferrara, R; Cassard, Lydie; Jouniaux, Jean-Mehdi; Boselli, Lisa; Grivel, Jonathan; Desnoyer, Aude; Danlos, François-Xavier; Mezquita, Laura; Caramella, Caroline; Marabelle, Aurelien; Besse, Benjamin; Chaput, Nathalie
Characterization of patients with metastatic non-small-cell lung cancer obtaining long-term benefit from immunotherapy
2019-01-01 G, Galli; C, Proto; D, Signorelli; M, Imbimbo; Ferrara, R; A, Prelaj; A De, Toma; M, Ganzinelli; N, Zilembo; F de, Braud; Mc, Garassino; G Lo, Russo
Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out
2019-01-01 Proto, C.; Ferrara, R; Signorelli, D.; Lo Russo, G.; Galli, G.; Imbimbo, M.; Prelaj, A.; Zilembo, N.; Ganzinelli, M.; Pallavicini, L. M.; De Simone, I.; Colombo, M. P.; Sica, A.; Torri, V.; Garassino, M. C.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A Case of William's Syndrome in a Ugandan Child: A Feasible Diagnosis Even in a Low-Resource Setting | 1-gen-2021 | Mapelli, Massimo; Zagni, Paola; Calbi, Valeria; Twalib, Aliku; Ferrara, R; Agostoni, Piergiuseppe | |
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report | 1-gen-2015 | C, Ciccarese; Ferrara, R; E, Fantinel; C, Zecchetto; F, Simionato; E, Grego; S, Ortolani; M, Caccese; D, Bimbatti; S, Cingarlini; M, Brunelli; A, Andreini; G, Tortora; F, Massari | |
Adenosine Pathway in NSCLC With Molecular Drivers: Can Oncogene Addiction Translate Into Immune Addiction? | 1-gen-2022 | Ferrara, R; Milani, Matteo; Garassino Marina, Chiara; Colombo Mario, Paolo; Sangaletti, Sabina | |
Adjuvant epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for the treatment of people with resected stage I to III non‐small‐cell lung cancer and EGFR mutation | 1-gen-2022 | Occhipinti, Mario; Ferrara, R; Imbimbo, Martina; Simeon, Vittorio; Fiscon, Giulia; Marchal, Corynne; Skoetz, Nicole; Viscardi, Giuseppe | |
Adjuvant therapy for resected early-stage small-cell lung cancer: is now time to rethink about that? | 1-gen-2016 | Ferrara, Roberto; Caccese, Mario; Cuppone, Federica; Bria, Emilio; Tortora, Giampaolo; Pilotto, Sara | |
Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: a retrospective international multicentre study | 1-gen-2018 | Lai W., Victoria; Lebas, Louisiane; Barnes Tristan, A.; Milia, Julie; Ni, Ai; Gautschi, Oliver; Peters, Solange; Ferrara, R; Plodkowski Andrew, J.; Kavanagh, John; Sabari Joshua, K.; Clarke Stephen, J.; Pavlakis, Nick; Drilon, Alexander; Rudin Charles, M.; Arcila Maria, E.; Leighl Natasha, B.; Shepherd Frances, A.; Kris Mark, G.; Mazières, Julien; Li Bob, T. | |
ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations | 1-gen-2016 | Peretti, U.; Ferrara, R; Pilotto, S.; Kinspergher, S.; Caccese, M.; Santo, A.; Brunelli, M.; Caliò, A.; Carbognin, L.; Sperduti, I.; Garassino, M.; Chilosi, M.; Scarpa, A.; Tortora, G.; Bria, E. | |
An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer | 1-gen-2015 | Pilotto, Sara; Novello, Silvia; Peretti, Umberto; Kinspergher, Stefania; Ciuffreda, Ludovica; Milella, Michele; Carbognin, Luisa; Vavalà, Tiziana; Ferrara, Roberto; Caccese, Mario; Tortora, Giampaolo; Bria, Emilio | |
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers-Letter | 1-gen-2018 | Ferrara, R; Susini, Sandrine; Marabelle, Aurelien | |
Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer | 1-gen-2018 | Mezquita, Laura; Auclin, Edouard; Ferrara, R; Charrier, Melinda; Remon, Jordi; Planchard, David; Ponce, Santiago; Ares Luis, Paz; Leroy, Laura; Audigier-Valette, Clarisse; Felip, Enriqueta; Zerón-Medina, Jorge; Garrido, Pilar; Brosseau, Solenn; Zalcman, Gérard; Mazieres, Julien; Caramela, Caroline; Lahmar, Jihene; Adam, Julien; Chaput, Nathalie; Soria Jean, Charles; Besse, Benjamin | |
Association of the prognostic model iSEND with PD-1/L1 monotherapy outcome in non-small-cell lung cancer | 1-gen-2020 | Park, Wungki; Mezquita, Laura; Okabe, Naoyuki; Chae Young, Kwang; Kwon, Deukwoo; Saravia, Diana; Auclin, Edouard; Planchard, David; Caramella, Caroline; Ferrara, R; Agte, Sarita; Oh, Michael; Mudad, Raja; Jahanzeb, Mohammad; Suzuki, Hiroyuki; Besse, Benjamin; Lopes, Gilberto | |
Atypical patterns of response and progression in the era of immunotherapy combinations | 1-gen-2020 | Ferrara, R; Matos, Ignacio | |
Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors | 1-gen-2022 | Campochiaro, C.; Farina, N.; Tomelleri, A.; Ferrara, R.; Viola, S.; Lazzari, C.; De Luca, G.; Raggi, D.; Bulotta, A.; Matucci-Cerinic, M.; Necchi, A.; Garassino, M.; Gregorc, V.; Dagna, L. | |
Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis | 1-gen-2021 | Passiglia, Francesco; Cinquini, Michela; Bertolaccini, Luca; Del Re, Marzia; Facchinetti, Francesco; Ferrara, R; Franchina, Tindara; Larici Anna, R.; Malapelle, Umberto; Menis, Jessica; Passaro, Antonio; Pilotto, Sara; Ramella, Sara; Rossi, Giulio; Trisolini, Rocco; Novello, Silvia | |
Beyond First-Line Immunotherapy: Potential Therapeutic Strategies Based on Different Pattern Progressions: Oligo and Systemic Progression | 1-gen-2021 | Prelaj, Arsela; Pircher Chiara, Carlotta; Massa, Giacomo; Martelli, Valentino; Corrao, Giulia; Lo Russo, Giuseppe; Proto, Claudia; Ferrara, R; Galli, Giulia; De Toma, Alessandro; Genova, Carlo; Jereczek-Fossa Barbara, Alicja; Braud Filippo, De; Garassino Marina, Chiara; Rebuzzi Sara, Elena | |
Brief Report: Canadian Cancer Trials Group IND.227: A Phase 2 Randomized Study of Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma (NCT02784171) | 1-gen-2023 | Piccirillo, M. C.; Chu, Q.; Bradbury, P.; Tu, W.; Coschi, C. H.; Grosso, F.; Florescu, M.; Mencoboni, M.; Goffin, J. R.; Pagano, M.; Ciardiello, F.; Cecere, F. L.; Vincent, M.; Ferrara, R.; Dawe, D. E.; Hao, D.; Lee, C. W.; Morabito, A.; Gridelli, C.; Cavanna, L.; Iqbal, M.; Blais, N.; Leighl, N. B.; Wheatley-Price, P.; Tsao, M. -S.; Ugo, F.; El-Osta, H.; Gargiulo, P.; Gaudreau, P. -O.; Tu, D.; Sederias, J.; Brown-Walker, P.; Perrone, F.; Seymour, L.; Laurie, S. A. | |
Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists' perspective | 1-gen-2020 | Lambertini, Matteo; Toss, Angela; Passaro, Antonio; Criscitiello, Carmen; Cremolini, Chiara; Cardone, Claudia; Loupakis, Fotios; Viscardi, Giuseppe; Meattini, Icro; Dieci Maria, Vittoria; Ferrara, R; Giusti, Raffaele; Maio Massimo, Di | |
CD8+PD-1+ to CD4+PD-1+ ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockers | 1-gen-2022 | Duchemann, Boris; Naigeon, Marie; Auclin, Edouard; Ferrara, R; Cassard, Lydie; Jouniaux, Jean-Mehdi; Boselli, Lisa; Grivel, Jonathan; Desnoyer, Aude; Danlos, François-Xavier; Mezquita, Laura; Caramella, Caroline; Marabelle, Aurelien; Besse, Benjamin; Chaput, Nathalie | |
Characterization of patients with metastatic non-small-cell lung cancer obtaining long-term benefit from immunotherapy | 1-gen-2019 | G, Galli; C, Proto; D, Signorelli; M, Imbimbo; Ferrara, R; A, Prelaj; A De, Toma; M, Ganzinelli; N, Zilembo; F de, Braud; Mc, Garassino; G Lo, Russo | |
Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out | 1-gen-2019 | Proto, C.; Ferrara, R; Signorelli, D.; Lo Russo, G.; Galli, G.; Imbimbo, M.; Prelaj, A.; Zilembo, N.; Ganzinelli, M.; Pallavicini, L. M.; De Simone, I.; Colombo, M. P.; Sica, A.; Torri, V.; Garassino, M. C. |